Butler Hall urges Vanda’s Board to adhere to its fiduciary duty to shareholders and run a full sales process following three new unsolicited offers for the Company
Butler Hall believes a sales process could yield fair value of $13.00-$22.00 per share
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Butler Hall Capital LLC has issued a 2nd letter to the board of directors (the “Board”) of Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”), urging the Board to immediately form an independent special committee to run a full sales process to achieve the highest possible value for shareholders.
A full copy of the letter is attached below and is available at:
http://ml.globenewswire.com/Resource/Download/5a126a16-cdc1-453f-a910-4754646cf0b8
Contacts: Michael Rybak 424-644-6008 Brad Lundy 424-644-6009
